Humana Inc. $HUM Position Increased by Voya Investment Management LLC

Voya Investment Management LLC lifted its stake in Humana Inc. (NYSE:HUM) by 84.3% during the third quarter, Holdings Channel reports. The fund owned 290,225 shares of the insurance provider’s stock after acquiring an additional 132,712 shares during the quarter. Voya Investment Management LLC’s holdings in Humana were worth $75,508,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Elevation Point Wealth Partners LLC bought a new stake in shares of Humana during the 2nd quarter worth $32,000. AlphaCore Capital LLC bought a new position in Humana during the second quarter valued at about $39,000. CVA Family Office LLC raised its stake in shares of Humana by 63.4% in the second quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock valued at $54,000 after purchasing an additional 85 shares in the last quarter. Traub Capital Management LLC acquired a new position in shares of Humana in the 2nd quarter valued at $61,000. Finally, Ransom Advisory Ltd bought a new position in Humana during the first quarter worth about $66,000. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Shares of NYSE HUM opened at $259.70 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02. The firm has a market cap of $31.23 billion, a price-to-earnings ratio of 24.34, a P/E/G ratio of 1.53 and a beta of 0.46. The stock’s fifty day moving average price is $259.48 and its two-hundred day moving average price is $259.22. Humana Inc. has a one year low of $206.87 and a one year high of $315.35.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The company had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. During the same quarter in the previous year, the business posted $4.16 earnings per share. Humana’s quarterly revenue was up 11.1% on a year-over-year basis. On average, equities analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio (DPR) is 33.18%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Truist Financial cut their price objective on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a report on Monday, November 10th. Wells Fargo & Company lifted their target price on Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Sanford C. Bernstein boosted their price target on shares of Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. KeyCorp reissued a “sector weight” rating on shares of Humana in a research note on Friday, December 12th. Finally, Mizuho lifted their price target on shares of Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Nine investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $294.32.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.